;

Search Results:

Showing of 50

CLINICAL TRIAL17753

Focal Prostate Radio-Frequency Ablation for the Treatment of Prostate Cancer

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18492

A Single-arm, Phase 2 Study to Evaluate the Safety and Efficacy of VT-464 in Patients with Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL17981

A Pilot Study of Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18523

A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African-American and Non-African American Men with Prostate Cancer (VANDAAM Study)

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18855

Multicenter, Open-label, Phase 1, Dose-escalation,Cohort-expansion, First-in-Human Study of KHK2455 Administered as Monotherapy and in Combination with Mogamulizumab (KW-0761) in Adult Subjects with Locally Advanced or Metastatic Solid Tumors

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18495

Caregiver Relationship Quality and Communication in Advanced Cancer Care

Cancer Type: Multiple

View Trial Details

CLINICAL TRIAL18643

Biobank for African American Prostate Cancer Research in Florida

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18201

A Phase I Dose Escalation Study of Preoperative Stereotactic Body Radiation Therapy (SBRT) for High Risk Prostate Cancer

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18885

A Randomized, Double-Blind, Placebo-Controlled Phase III Study of ODM-201 Versus Placebo in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18986

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency.

Cancer Type: Genitourinary

View Trial Details

CLINICAL TRIAL18963

A Phase III, Open Label, Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza) Versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment with a New Hormonal Agent and Have Homologous Recombination Repair Gene Mutations (Profound)

Cancer Type: Genitourinary

View Trial Details